HASHEM EL-SERAG to Fatty Liver
This is a "connection" page, showing publications HASHEM EL-SERAG has written about Fatty Liver.
Connection Strength
1.533
-
Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings From the Texas Hepatocellular Carcinoma Consortium Cohort. Gastroenterology. 2020 07; 159(1):376-377.
Score: 0.539
-
Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol. 2012 Dec; 10(12):1342-1359.e2.
Score: 0.321
-
Clinical Care Pathway for the Risk Stratification and Management of Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. Gastroenterology. 2026 Jul; 171(1):164-183.
Score: 0.203
-
Evolving burden of metabolic dysfunction-associated steatotic liver disease and its complications in a US nationwide healthcare system. Hepatol Commun. 2026 Jan 01; 10(1).
Score: 0.201
-
Accurate Identification of Fatty Liver Disease in Data Warehouse Utilizing Natural Language Processing. Dig Dis Sci. 2017 10; 62(10):2713-2718.
Score: 0.113
-
Dietary history and physical activity and risk of advanced liver disease in veterans with chronic hepatitis C infection. Dig Dis Sci. 2011 Jun; 56(6):1835-47.
Score: 0.071
-
GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. JAMA Intern Med. 2024 11 01; 184(11):1314-1323.
Score: 0.046
-
Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002 Jul; 36(1):227-42.
Score: 0.039